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On the Dutch Registry of
catheter ablation of atrial
fibrillation
We would like to submit a reaction to the paper
on the Dutch Registry on pulmonary vein isola-
tion.1 The authors present a nice overview of the
outcome of pulmonary vein isolation in their
country in the years 2012–2017, however with a
rather weak follow-up. The strength of the paper
lies in the numbers.
That an almost forgotten technique was used to
compose one group does not matter: pulsed
radiofrequency (RF) or Pulmonary Vein Ablation
Catheter (PVAC) (which was only submitted to a
small randomized trial, not showing a real benefit
vs. conventional RF) seemed almost as good as
conventional RF. Therefore, it has finally merited a
place in clinical electrophysiology.2
The article focuses on complications (which
was the title, and the registry probably was
designed to show these data), and not on efficacy
of the various techniques, which is more difficult.
However, this is a missed opportunity. The
European Registry showed already the excess of
complications in women.3
A first question is whether the design of the pa-
per does not underestimate the real number of
the complications. The overall number seems to
be very acceptable. Follow-up was incomplete,
and mortality was lacking in a few centres. The
only drawback of cryoballoon ablation was the
presence of phrenic nerve damage. It is a pity that
no effort was performed to see whether this
complication remained present at 3 months. If we
count the other complications (except mortal-
ity)—it becomes 160/5976 (2.67%) for RF vs.
140/5108 (2.74%) for cryo. The number for
phased RF is ridiculously low. Furthermore, com-
plications as pulmonary vein stenosis were not
specifically mentioned.4
The second point is the missed chance to com-
ment on efficacy. The data are in the report, but
not mentioned. A repeat ablation is a good surro-
gate for efficacy, and also for comparative efficacy
in the three groups. It is not remarkable that con-
ventional RF and PVAC result in 20, respectively
26% re-ablation vs. 13% for the cryoballoon. This
could have been predicted from published ran-
domized trials of cryo vs. RF, and from extrapolat-
ing various recent observational studies.5 This
becomes even more striking when one considers
that 30% of the RF group already had a re-ablation
as entry in the Registry. This might be a bias, as
the number of persistent patients was higher in
the conventional RF group. Some data have now
been published on the efficacy of cryoballoon ab-
lation on persistent atrial fibrillation as well.
Furthermore, the number of persistent patients in
the PVAC group was similar to the proportion in
the cryoballoon group, whereas the number of
repeat procedures in the cryoballoon group was
only half that of PVAC.
On might ask therefore whether PVAC still has
a place, and this should have been one of the con-
clusions. Furthermore, if a patient is selected for
conventional RF, he should be informed that his
chances for a repeat procedure are probably
higher than when a cryoballoon procedure is
intended. More recent improvement of both
techniques probably did not change the outcome
of the cards. . .
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